The Eye On Line (EOL) device represents a novel approach to assist ALS patients in communication, addressing a significant unmet need in this patient population. The market for assistive communication devices is growing, driven by the increasing prevalence of neurodegenerative diseases. The EOL device's unique mechanism of utilizing smooth pursuit eye movements for writing could differentiate it from existing solutions, potentially capturing a niche market. Competitive analysis indicates a limited number of similar devices, suggesting a favorable position for EOL if proven effective. Diligence should focus on regulatory pathways, reimbursement strategies, and partnerships with ALS advocacy groups to enhance market penetration.